Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300074297Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial of ciprofol and propofol in coronary arteriosclerosis and carotid atheroma (CAS) (3 arms), sponsored by General Hospital of the Northern War Zone of the Chinese People's Liberation Army. Primary endpoint: Area under baseline of mean arterial pressure after administration. Planned start Aug 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300074297.